北京天坛医院成立国内首个脑机接口临床与转化病房

Core Viewpoint - The establishment of the first clinical and translational ward for brain-computer interface (BCI) technology in China aims to transition BCI development from research-driven to clinically-driven applications [1][3][4]. Group 1: Clinical and Research Collaboration - The ward is a collaborative effort led by Beijing Tiantan Hospital, involving multiple research institutions such as Tsinghua University and the Chinese Academy of Sciences [3]. - It will conduct clinical trials for the "Beijing Brain No. 1" BCI device and establish a collaborative innovation system integrating medical, engineering, research, production, and government sectors [3][4]. Group 2: Training and Standards Development - The ward will organize nationwide multi-center clinical trials and develop ethical guidelines, admission standards, and clinical pathway guidelines for BCI technology [3][4]. - It aims to create a training platform for clinical doctors, engineering technicians, and researchers, fostering talent development in the BCI field [3][4]. Group 3: Technological Integration and Patient Care - The ward will feature an integrated BCI technology platform with advanced equipment for patient assessment, regulation, and training, focusing on improving the quality of life for patients with severe conditions [4]. - The goal is to transition BCI technology from prototypes to bedside applications, enhancing patient outcomes through innovative solutions [4]. Group 4: Future Vision and Impact - The director of the National Clinical Research Center for Neurological Diseases emphasized the importance of BCI as a key entry point for future medicine, aiming for breakthroughs that benefit the public [4]. - The hospital's leadership expressed commitment to leveraging its platform to transform high-level innovations into quality healthcare services, addressing public demand for improved health outcomes [4].